RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PONTALI E
Collezione ASL Vercelli

Items : 3

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial in Cell Reports Medicine

2023
ASL Vercelli

Capone S; Fusco FM; Milleri S; Borrè S; Carbonara S; Lo Caputo S; Leone S; Gori G; Maggi P; Cascio A; Lichtner M; Cauda R; Dal Zoppo S; Cossu MV; Gori A; Roda S; Confalonieri P; Bonora S; Missale G; Codeluppi M; Mezzaroma I; Capici S; Pontali E; Libanore M; Diani A; Lanini S; Battella S; Contino AM; Piano Mortari E; et alii...

GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR) in medRxiv

2022
ASL Vercelli

Capone S; Fusco FM; Milleri S; Borrè S; Carbonara S; Caputo SL; Leone S; Gori G; Maggi P; Cascio A; Lichtner M; Cauda R; Zoppo SD; Cossu MV; Gori A; Roda S; Confalonieri P; Bonora S; Missale G; Codeluppi M; Mezzaroma I; Capici S; Pontali E; Libanore M; Diani A; Lanini S; Battella S; Contino AM; Mortari EP; et alii...

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial in Journal of Translational Medicine

2020
ASL Vercelli

Perrone F; Piccirillo MC; Ascierto PA; Salvarani C; Parrella R; Marata AM; Popoli P; Ferraris L; Marrocco-trischitta MM; Ripamonti D; Binda F; Bonfanti P; Squillace N; Castelli F; Muiesan ML; Lichtner M; Calzetti C; Salerno ND; Atripaldi L; Cascella M; Costantini M; Dolci G; Facciolongo NC; Fraganza F; Massari M; Montesarchio V; Mussini C; Negri EA; Botti G; et alii...